{
  "home": {
    "introduction": "Introduction",
    "essentialInfo": "Essential Info",
    "activeDisease": "Disease Activity",
    "postpartum": "Postpartum",
    "postpartum_mum": "Post-partum Mum",
    "questions": "Tell Us About You",
    "quiz_for_you": "Questions for You",
    "pregnancy": "Pregnancy",
    "disease": "Disease",
    "value_survey": "Values Survey",
    "surgery": "Surgery",
    "yourSummary": "Your Summary",
    "preconception": "Preconception",
    "fertility": "Fertility",
    "contraception": "Contraception",
    "pre_medications": "Medications",
    "inheritance": "Inheritance",
    "surgeries": "Surgery",
    "medication": "Medication List",
    "delivery": "Delivery",
    "preg_medications": "Medications",
    "breastfeeding": "Feeding Your Infant",
    "post_medications": "Medications",
    "nutrition": "Nutrition",
    "substance_use": "Substance Use",
    "infants": "Infants",
    "opinion_review": "Opinion Review",
    "summary": "Your Summary",
    "summary_title": "Summary",

    "internalPages": {
      "medicationP1": "My Medication List",
      "medicationP2": "Medications - MTX",
      "medicationP3": "Biologics",
      "medicationP4": "Opinions Now",
      "medicationP5": "My Medication Information",
      "medicationP6": "Opinion Review",
      "forms": {
        "notSafe": "Not Safe",
        "safe": "Safe",
        "notConcerned": "Not Concerned",
        "concerned": "Concerned",
        "continue": "Continue",
        "discontinue": "Discontinue",
        "notImportant": "Not Important",
        "important": "Important"
      }
    },
    "forms": {
      "pregnant": "I'm pregnant",
      "preconception": "I'm preconception",
      "ulcerative": "ulcerative COLITIS",
      "crohns": "Crohns Disease",
      "perianal": "Perianal Disease",
      "notSure": "I'm not sure",
      "jPouch": "JPouch",
      "colostomy": "Colostomy/Ileostomy",
      "colectomy": "Colectomy",
      "ileal": "Ileal/Ileocolonic Resection",
      "noSurgeries": "No surgeries",
      "yes": "Yes",
      "no": "No",
      "unsure": "Unsure",
      "active": "Active",
      "inactive": "Inactive",
      "multiSelect": {
        "none": "None",
        "yes": "Yes",
        "no": "No",
        "aminosalicylates": "Aminosalicylates",
        "5-aminosalicylates": "5-aminosalicylates",
        "sulfasalazine": "Sulfasalazine",
        "immunomodulator": "Immunomodulator",
        "corticosteroids": "Corticosteroids",
        "calcineurinInhibitor": "Calcineurin Inhibitor",
        "otherAminosalicylates": "Other Aminosalicylates, including Pentasa®, Asacol®, Salofalk®, Mezavant®, and generics",
        "methotrexate": "Methotrexate",
        "allopurinol": "Allopurinol",
        "thiopurinesIncluding": "THIOPURINES including 6-mercaptopurine (Purinethol®) and Azathioprine (Imuran®)",
        "biologics": "Biologics",
        "antiTnfs": "Anti TNF: Remicade® (Infliximab), Inflectra® (Infliximab), Humira®(Adalimumab), Simponi® (Golimumab)",
        "vedolizumab": "Entyvio® (Vedolizumab)",
        "ustekinumab": "Stelara® (Ustekinumab)",
        "smallMolecules": "Small molecule",
        "antibiotics": "Antibiotics",
        "ciprofloxacin": "Ciprofloxacin",
        "metronidazole": "Metronidazole",
        "vancomycin": "Vancomycin",
        "mesalamine": "Mesalamine including Pentasa®, Asacol®, Salofalk®, Mezavant®, and generics",
        "cyclosporin": "Cyclosporin",
        "penicillin": "Pencillin based",
        "imuran": "Imuran® (Azathioprine)",
        "purinethol": " Purinethol® (6-mercaptopurine)",
        "tofacitinib": "Tofacitinib (Xeljanz®)",
        "steriods": "Steroids",
        "prednisone": "Prednisone/Prednisolone",
        "methylprednisolone": "Methylprednisolone",
        "hydrocortisone": "Hydrocortisone",
        "budesonide": "Budesonide",
        "intravenous": "Intravenous, including Methylprednisolone and Hydrocortisone",
        "test": "test",
        "test2": "test"
      }
    },
    "definitions": {
      "jpouch": "JPouch",
      "preconception": "Preconception",
      "crohns": "Crohns Disease",
      "ulcerative": "Ulcerative Colitis",
      "colestomy": "Colostomy/Ileostomy",
      "colectomy": "Colectomy",
      "ileal": "Ileal/Ileocolonic Resection",
      "perianal": "Perianal Disease",
      "definedTerm": "Example Term"
    },
    "feedback": {
      "option1": "Likelihood of my baby being exposed to any drug during in utero development.",
      "option2": "Likelihood my baby being born with detectable drug in their bloodstream?",
      "option3": "The possible need to start steroids during pregnancy due to active IBD",
      "option4": "The risk my IBD will flare during pregnancy",
      "option5": "The possible need to start or restart a stopped medication due to active IBD",
      "option6": "Exposing my baby to a medication for which we only have limited information on safety for pregnancy (for example, small number of patients who have received the medication in pregnancy or short duration of follow up of infants)"
    },
    "medicationSelection": {
      "aminosalicylatessulfasalazine": {
        "pregnant": {
          "medications": "Inhibits folate synthesis. Women taking this medication should also be taking folic acid supplements (2 – 3 mg per day) throughout pregnancy"
        },
        "preconception": {
          "medications": "Inhibits folate synthesis. Women taking this medication who are hoping to conceive should also be taking folic acid supplements (2 – 3 mg per day)"
        },
        "breastfeeding": "Passage into the breastmilk in such small amounts that there is minimal concern.\nThere have been rare reports of 5-ASA hypersensitivity in the breast fed infant, leading to bloody diarrhea.  If your baby has bloody diarrhea, take baby to your family physician or pediatrician. Discuss with your GI if it is felt the 5-ASA is causing the bloody diarrhea as you will need to find another therapy.",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "No known impact on infant risk"
      },
      "aminosalicylatesotherAminosalicylates": {
        "pregnant": {
          "medications": "If you are taking Asacol® and are pregnant, it is not recommended to switch to another 5 ASA as there is a small risk of flaring with switching, even if it does have the DBP coating."
        },
        "preconception": {
          "medications": "Some formulations of Asacol® contain a chemical in the coating (DBP) that may pose a very small risk to the fetal development. If your prescribed Asacol (check with your gastroenterologist or pharmacist) does have this coating, consider switching to another 5 ASA."
        },
        "breastfeeding": "Passage into the breastmilk in such small amounts that there is minimal concern.\nThere have been rare reports of 5-ASA hypersensitivity in the breast fed infant, leading to bloody diarrhea.  If your baby has bloody diarrhea, take baby to your family physician or pediatrician. Discuss with your GI if it is felt the 5-ASA is causing the bloody diarrhoea as you will need to find another therapy.",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "No known impact on infant risk"
      },
      "5-aminosalicylatessulfasalazine": {
        "pregnant": {
          "medications": "Inhibits folate synthesis. Women taking this medication should also be taking folic acid supplements (2 – 3 mg per day) throughout pregnancy"
        },
        "preconception": {
          "medications": "Inhibits folate synthesis. Women taking this medication who are hoping to conceive should also be taking folic acid supplements (2 – 3 mg per day)"
        },
        "breastfeeding": "Passage into the breastmilk in such small amounts that there is minimal concern.\nThere have been rare reports of 5-ASA hypersensitivity in the breast fed infant, leading to bloody diarrhea.  If your baby has bloody diarrhea, take baby to your family physician or pediatrician. Discuss with your GI if it is felt the 5-ASA is causing the bloody diarrhea as you will need to find another therapy.",
        "vaccinations": "",
        "infections": ""
      },
      "5-aminosalicylatesmesalamine": {
        "pregnant": {
          "medications": "No known concerns."
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "Passage into the breastmilk in such small amounts that there is minimal concern.\nThere have been rare reports of 5-ASA hypersensitivity in the breast fed infant, leading to bloody diarrhea.  If your baby has bloody diarrhea, take baby to your family physician or pediatrician. Discuss with your GI if it is felt the 5-ASA is causing the bloody diarrhoea as you will need to find another therapy.",
        "vaccinations": "",
        "infections": ""
      },
      "corticosteroidsbudesonide": {
        "preconception": {
          "medications": "No known concerns. However, it is recommended for you to be in remission on stable maintenance medication for at least 3 months prior to attempting to conceive."
        },
        "pregnant": {
          "medications": "Limited information regarding use in pregnancy. Use in pregnancy is considered safe from available information."
        },
        "breastfeeding": "",
        "vaccinations": "",
        "infections": ""
      },
      "corticosteroidsprednisone": {
        "preconception": {
          "medications": "No known concerns. However, it is recommended for you to be in remission on stable maintenance medication for at least 3 months prior to attempting to conceive."
        },
        "pregnant": {
          "medications": "There is a small risk of cleft palate development associated with steroid use in the first trimester. There is also additional associated risks including gestational diabetes, but the risks of not using steroids with active disease are usually higher than taking steroids to control active disease. Suggest discussion with your obstetrician and gastroenterologist as there may also be the options of steroid sparing medications such as biologics."
        },
        "breastfeeding": "At doses &gt;20mg, delay feeding 3-4 h after dose",
        "vaccinations": "",
        "infections": ""
      },
      "corticosteroidsmethylprednisolone": {
        "preconception": {
          "medications": "No known concerns. However, it is recommended for you to be in remission on stable maintenance medication for at least 3 months prior to attempting to conceive."
        },
        "pregnant": {
          "medications": "If intravenous steroids are required, preferential use of hydrocortisone is recommended due to how the placenta metabolises steroids."
        },
        "breastfeeding": "",
        "vaccinations": "",
        "infections": ""
      },
      "corticosteroidshydrocortisone": {
        "preconception": {
          "medications": "No known concerns. However, it is recommended for you to be in remission on stable maintenance medication for at least 3 months prior to attempting to conceive."
        },
        "pregnant": {
          "medications": "If intravenous steroids are required, preferential use of hydrocortisone is recommended due to how the placenta metabolises steroids."
        },
        "breastfeeding": "",
        "vaccinations": "",
        "infections": ""
      },
        "immunomodulatorimuran": {
        "pregnant": {
          "medications": "Monitor maternal blood counts (CBC/FBC) monthly. It is recommended not to start during pregnancy (small risk of drug reaction, including pancreatitis.)"
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "The limited number of studies that have been done show that the amount of medication passed through breast milk is in very small amounts and it is acceptable to take while breastfeeding. Given there is one small report of anaemia in an infant, consider checking infant blood count (CBC) at birth.",
        "vaccinations": "",
        "infections": ""
      },
        "immunomodulatorpurinethol": {
        "pregnant": {
          "medications": "Monitor maternal blood counts (CBC/FBC) monthly. It is recommended not to start during pregnancy (small risk of drug reaction, including pancreatitis.)"
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "The limited number of studies that have been done show that the amount of medication passed through breast milk is in very small amounts and it is acceptable to take while breastfeeding. Given there is one small report of anaemia in an infant, consider checking infant blood count (CBC) at birth.",
        "vaccinations": "",
        "infections": ""
      },
        "immunomodulatormethotrexate": {
        "pregnant": {
          "medications": "If you become pregnant while taking methotrexate, stop taking the methotrexate immediately and schedule an urgent appointment with your doctor or obstetric care provider. Notify your gastroenterologist as well, as they may have to find another medication."
        },
        "preconception": {
          "medications": "Methotrexate can be harmful in pregnancy causing embryo malformation and fetal death. Discontinue use at least 3 months prior to trying to conceive (women and men)."
        },
        "breastfeeding": "Most experts recommend not to breastfeed while on Methotrexate. If a decision is made to breastfeed, it is recommended to withhold breastfeeding for 24 hours after a weekly dose. Monitoring of the infant's blood count (CBC) could be considered.",
        "vaccinations": "",
        "infections": ""
      },
        "methotrexateyes": {
        "pregnant": {
          "medications": "If you become pregnant while taking methotrexate, stop taking the methotrexate immediately and schedule an urgent appointment with your doctor or obstetric care provider. Notify your gastroenterologist as well, as they may have to find another medication"
        },
        "preconception": {
          "medications": "Methotrexate can be harmful in pregnancy causing embryo malformation and fetal death. Discontinue use at least 3 months prior to trying to conceive (women and men)."
        },
        "breastfeeding": "Most experts recommend not to breastfeed while on Methotrexate. If a decision is made to breastfeed, it is recommended to withhold breastfeeding for 24 hours after a weekly dose. Monitoring of the infant's blood count (CBC) could be considered.",
        "vaccinations": "",
        "infections": ""
      },
       "immunomodulatorallopurinol": {
        "pregnant": {
          "medications": "Note allopurinol is not an immunosuppressant however may be used to help the action of azathioprine or 6MP. There is conflicting information surrounding the use of allopurinol in pregnancy, with some studies suggesting safety and others reporting fetal harm. Accordingly, while safety of use in pregnancy cannot be reassured, stopping allopurinol in pregnancy is not advised prior to consultation with your gastroenterologist."
        },
        "preconception": {
          "medications": "Note allopurinol is not an immunosuppressant however may be used to help the action of azathioprine or 6MP. There is conflicting information surrounding the safety of use of allopurinol in pregnancy, with some studies suggesting safety and others reporting fetal harm. Accordingly, while safety of use in pregnancy cannot be reassured, it is suggested you discuss with your gastroenterologist potentially revising the use of allopurinol prior to becoming pregnant."
        },
        "breastfeeding": "",
        "vaccinations": "",
        "infections": ""
      },
        "allopurinolyes": {
        "pregnant": {
          "medications": "Note allopurinol is not an immunosuppressant however may be used to help the action of azathioprine or 6MP. There is conflicting information surrounding the use of allopurinol in pregnancy, with some studies suggesting safety and others reporting fetal harm. Accordingly, while safety of use in pregnancy cannot be reassured, stopping allopurinol in pregnancy is not advised prior to consultation with your gastroenterologist."
        },
        "preconception": {
          "medications": "Note allopurinol is not an immunosuppressant however may be used to help the action of azathioprine or 6MP. There is conflicting information surrounding the safety of use of allopurinol in pregnancy, with some studies suggesting safety and others reporting fetal harm. Accordingly, while safety of use in pregnancy cannot be reassured, it is suggested you discuss with your gastroenterologist potentially revising the use of allopurinol prior to becoming pregnant."
        },
        "breastfeeding": "Exclusively breastfed infants should be monitored, including observation for allergic reactions (such as rash) and periodic blood count (CBC).",
        "vaccinations": "",
        "infections": ""
      },
        "thiopurinesIncludingyes": {
        "pregnant": {
          "medications": "Monitor maternal blood counts (CBC) monthly. It is recommended not to start during pregnancy (small risk of drug reaction, including pancreatitis). Given there is one small report of anaemia in an infant, consider checking infant blood count (CBC) at birth."
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "The limited number of studies that have been done show that the amount of medication passed through breast milk is in very small amounts and it is acceptable to take while breastfeeding.",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "When thiopurines have been used in combination with anti-TNFs during pregnancy, there has been identification of a small increased risk of common infections in the infant, such as ear and upper respiratory tract infections within the first 12 months of life."
      },
      "biologicsantiTnfs": {
        "pregnant": {
          "medications": "Anti-TNFs are considered safe to use throughout pregnancy."
        },
        "preconception": {
          "medications": "There are no known concerns regarding fertility and conceiving while on an anti-TNF."
        },
        "breastfeeding": "",
        "vaccinations": "Babies exposed to anti-TNF in utero should NOT receive LIVE vaccines for the first 9 to 12 months of life. All other vaccinations should be given.",
        "infections": ""
      },
      "biologicsvedolizumab": {
        "pregnant": {
          "medications": "There was limited information available at the time this resource was created. However, from what is available, no concerns have been identified."
        },
        "preconception": {
          "medications": "There was limited information available at the time this resource was created. However, from what is available, no new concerns have been identified when compared with anti-TNFs."
        },
        "breastfeeding": "At this time, there is not enough data on vedolizumab. They are very similar to anti-TNF medications and it is likely that there are also only small amounts in breast milk. Women should discuss whether or not to continue taking these medications while they are breastfeeding with their doctors.",
        "vaccinations": "",
        "infections": ""
      },
      "biologicsustekinumab": {
        "pregnant": {
          "medications": "There was limited information available at the time this resource was created. However, from what is available from the use in IBD and other conditions such as psoriasis and psoriatic arthritis, no concerns have been identified."
        },
        "preconception": {
          "medications": "There was limited information available at the time this resource was created. However, from what is available, no new concerns have been identified when compared with anti-TNFs."
        },
        "breastfeeding": "There was limited information available at the time this resource was created. However, from what is available, no new concerns have been identified when compared with anti-TNFs.",
        "vaccinations": "Babies exposed to ustekinumab in utero should NOT receive LIVE vaccines for the first 9 to 12 months of life. All other vaccinations should be given",
        "infections": "There was limited information available at the time this resource was created. However from what is available, no new concerns have been identified when compared with anti-TNFs."
      },
        "smallMoleculestofacitinib": {
        "pregnant": {
          "medications": "There was limited information available at the time this resource was created. However, animal studies using very high doses of tofacinitib have shown harm to the foetus, therefore use in pregnancy is currently not advised. If you become pregnant while on tofacinitib, please contact your Gastroenterologist."
        },
        "preconception": {
          "medications": "There was limited information available at the time this resource was created. However, animal studies using very high doses of tofacinitib have shown harm to the foetus, therefore use in pregnancy is currently not advised. "
        },
        "breastfeeding": "",
        "vaccinations": "",
        "infections": ""
      },
        "smallMoleculesyes": {
        "pregnant": {
          "medications": "There was limited information available at the time this resource was created. However, animal studies using very high doses of tofacinitib have shown harm to the foetus, therefore use in pregnancy is currently not advised. If you become pregnant while on tofacinitib, please contact your Gastroenterologist."
        },
        "preconception": {
          "medications": "There was limited information available at the time this resource was created. However, animal studies using very high doses of tofacinitib have shown harm to the foetus, therefore use in pregnancy is currently not advised. "
        },
        "breastfeeding": "No information is available on the clinical use of tofacitinib during breastfeeding.",
        "vaccinations": "Insufficent information is available at the time this resource was created to advise.",
        "infections": "There was minimal information available at the time this resource was created."
      },
      "calcineurinInhibitorcyclosporin": {
        "pregnant": {
          "medications": ""
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "",
        "vaccinations": "",
        "infections": ""
      },
      "antibioticsciprofloxacin": {
        "pregnant": {
          "medications": "Very small risk of tendon damage with ciprofloxacin if used in first trimester"
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "Delay feeding 3-4 h after dose",
        "vaccinations": "",
        "infections": ""
      },
       "antibioticsmetronidazole": {
        "pregnant": {
          "medications": "No known concerns."
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "No known concerns.",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "No known impact on infant risk"
      },
      "antibioticspenicillin": {
        "pregnant": {
          "medications": "No known concerns."
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "No known concerns.",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "No known impact on infant risk"
      },
      "antibioticsvancomycin": {
        "pregnant": {
          "medications": "No known concerns."
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "No known concerns.",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "No known impact on infant risk"
      },
      "steriodsprednisone": {
        "pregnant": {
          "medications": "Associated risk include gestational diabetes, but the risks of not using steroids with active disease are usually higher than taking the medication.  Suggest discussion with your obstetrician and gastroenterologist."
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "At doses >20 mg, delay feeding 3-4 h after dose",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "In the first 4 months of life, there is a potential for small increase in infection"
      },
      "steriodsbudesonide": {
        "pregnant": {
          "medications": "Limited information regarding use in pregnancy. Use in pregnancy is considered safe from available information."
        },
        "preconception": {
          "medications": "No known concerns."
        },
        "breastfeeding": "No known concerns",
        "vaccinations": "All usual vaccinations, including live vaccines can be given.",
        "infections": "No known impact on infant risk"
      },
      "steriodsintravenous": {
        "pregnant": {
          "medications": "Preferential use of hydrocortisone is recommended due to how the placenta metabolises steroids."
        },
        "preconception": {
          "medications": ""
        },
        "breastfeeding": "Limited transfer of methylprednisolone into breastmilk; to minimise exposure, delay feeding 2 to 4 hours after dose. There is no data to support hydrocortisone use.",
        "vaccinations": "",
        "infections": ""
      },
      "testtest2": {
        "pregnant": {
          "medications": "Preferential use of hydrocortisone is recommended due to how the placenta metabolises steroids."
        },
        "preconception": {
          "medications": ""
        },
        "breastfeeding": "Limited transfer of methylprednisolone into breastmilk; to minimise exposure, delay feeding 2 to 4 hours after dose. There is no data to support hydrocortisone use.",
        "vaccinations": "",
        "infections": ""
      }
    }
  }
}
